Sarah B. Goldberg

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Scott Gettinger, Amit Mahajan et al. · The Lancet Oncology · 2016 · 996 citations · Full text

Medicine, Oncology, Pharmacology +16

Expression of bacterial genes in plant cells.

R.T. Fraley, Stephen G. Rogers, R. Horsch et al. · Proceedings of the National Academy of Sciences · 1983 · 844 citations · Full text

Agriculture, Plant Biology, Plant Sciences +11

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Scott Gettinger, Jungmin Choi, Katherine Hastings et al. · Cancer Discovery · 2017 · 755 citations · Full text

Life Sciences, Immunology, Oncology +17

Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer

Naiyer A. Rizvi, Byoung Chul Cho, Niels Reinmuth et al. · JAMA Oncology · 2020 · 628 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study

Scott Antonia, Sarah B. Goldberg, Ani Sarkis Balmanoukian et al. · The Lancet Oncology · 2016 · 594 citations · Full text

Medicine, Oncology, Pharmacology +15